Showing results (2291-2300 of 2,349) with videos related to
Sort By:
Pageof 235
Nature Communications|April 17, 2019
Supersonic plasma turbulence in the laboratoryT G White, M T Oliver, P Mabey, et al.Nature|April 9, 2025
Multimodal cell maps as a foundation for structural and functional genomicsLeah V Schaffer, Mengzhou Hu, Gege Qian, et al.Ophthalmology|March 18, 2018
The Decreasing Prevalence of Nonrefractive Visual Impairment in Older Europeans: A Meta-analysis of Published and Unpublished DataCécile Delcourt, Mélanie Le Goff, Therese von Hanno, et al.Science (New York, N.Y.)|November 1, 2014
Innate immunity. A Spaetzle-like role for nerve growth factor β in vertebrate immunity to Staphylococcus aureusLucy Hepburn, Tomasz K Prajsnar, Catherine Klapholz, et al.Ophthalmology|July 18, 2017
Prevalence of Age-Related Macular Degeneration in Europe: The Past and the FutureJohanna M Colijn, Gabriëlle H S Buitendijk, Elena Prokofyeva, et al.Nature|January 14, 2026
Language model-guided anticipation and discovery of mammalian metabolitesHantao Qiang, Fei Wang, Wenyun Lu, et al.Ophthalmology|May 7, 2023
Association of Systemic Medication Use with Glaucoma and Intraocular Pressure: The European Eye Epidemiology ConsortiumJoëlle E Vergroesen, Alexander K Schuster, Kelsey V Stuart, et al.European Journal of Epidemiology|September 11, 2016
Associations with intraocular pressure across Europe: The European Eye Epidemiology (E3) ConsortiumAnthony P Khawaja, Henriët Springelkamp, Catherine Creuzot-Garcher, et al.Journal of Medicinal Chemistry|March 11, 2024
Development of a Series of Pyrrolopyridone MAT2A InhibitorsStephen J Atkinson, Sharan K Bagal, Argyrides Argyrou, et al.The British Journal of Ophthalmology|November 7, 2022
Association of lipid-lowering drugs and antidiabetic drugs with age-related macular degeneration: a meta-analysis in EuropeansMatthias M Mauschitz, Timo Verzijden, Alexander K Schuster, et al.Pageof 235